Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEvraz Regulatory News (EVR)

  • This share is currently suspended. It was suspended at a price of 82.52

Share Price Information for Evraz (EVR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 82.52
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 82.52
EVR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on COVID-19

16 Apr 2020 14:00

RNS Number : 9171J
Evraz Plc
16 April 2020
 

Update on COVID-19

 

16 April 2020 - EVRAZ plc ("EVRAZ or the "Group") today announces an update on the impact of COVID-19 on its business.

Group focus and priorities

The Group is closely monitoring the development of the COVID-19 pandemic and its impact on our employees, our operations and the broader stakeholder base. EVRAZ's immediate focus is on doing everything in its power to protect the lives and health of our employees and minimise the negative impact on our facilities and the communities in which we operate.

During and since March 2020, in response to the coronavirus pandemic the Group has introduced additional safety measures to protect its people and ensure continued operations.

These include:

· Significant reduction of domestic and cancellation of overseas business travel;

· Two-week isolation, with full salary, for all employees returning from trips abroad, either personal or work-related;

· Enabling remote working, provision of additional personal protection equipment for employees who must come to work, including eye protectors, respirators and gloves;

· Installation of thermal imaging devices and pyrometers at the entrances to our facilities to monitor people's temperatures;

· Elimination to the extent possible of large gatherings (with social distancing when they must take place), and cancellation of all major corporate, sporting and entertainment events;

· Increase of supplies of antiseptic and disinfectant products in communal areas, regular sanitation of facilities and transport;

· Campaigns to raise awareness among employees and contractors on behavioural features, social distancing and personal protection.

The Group is monitoring the spread of coronavirus and working with healthcare facilities and insurance organisations to take proactive decisions aimed at safeguarding its employees and their families. Currently there are no confirmed COVID-19 cases in EVRAZ.

Update on our operations and outlook 

The Group remains closely focused on its operations, including logistics, supply and technological processes. At present, EVRAZ is facing no significant issues with the production or supply of raw materials and other goods. Shipments continue, and raw material deliveries to enterprises are stable.

However, in the near term, we expect domestic steel demand to fall due to the significant economic down-turn that the restrictions imposed due to COVID-2019 are causing worldwide, including in Russia. This will, no doubt, affect firstly our construction products sales and then our railway products sales, to a slightly lesser extent.

We expect the impact on exports to be less significant. This is due to the recent rouble devaluation and EVRAZ's ability to redirect steel from domestic sales to export markets.

While the impact on the Group has been limited so far, we are likely to experience challenges in the near term. While our enterprises have been operating at full capacity, the situation is likely to be more complex in May and June. In the light of this, EVRAZ is working on a comprehensive package of optimisation measures that we expect to partially mitigate these negative effects.

Our financial position

The Group remains well capitalised with a strong liquidity cushion.

As at 31 December 2019, our net debt amounted to US$3,445 million. This reflected cash of US$1,423 million. Short-term loans and the current portion of long-term loans stood at US$140 million. Total scheduled debt maturities during 2020 will amount to no more thanUS$52 million.

In March 2020, EVRAZ paid interim dividends to its shareholders amounting to US$580.8 million, US$0.40 per share.

In addition, also in March 2020, EVRAZ signed a US$750 million 5-year committed syndicated unsecured credit facility. This facility was arranged and fully underwritten by a group of 10 international banks and is available for drawing until 18 March 2021. The proceeds of the facility will be used for general corporate purposes, including refinancing of the public debt maturities upcoming in Q1 2021.  

In March and April, the Group also added RUB20 billion to its cash cushion by utilisation of its committed and uncommitted credit lines in Russia, due 2023.

The first sizeable maturities are due in Q1 2021 which should be comfortably covered by our existing cash balances and committed credit facilities.

Despite Covid-19 related challenges and market downturns, EVRAZ remains committed to its long-term strategic goals, sustainability principles and high standards of corporate governance and control.

 

For more information, please contact:

 

Investor Relations

Tel: +7 495 232 1370

Email: ir@evraz.com

 

Media Relations

Tel: +7 495 937 6871

Email: media@evraz.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDGPUAGCUPUGPQ
Date   Source Headline
28th Mar 20197:00 amRNSDirector/PDMR Shareholding
27th Mar 201910:00 amRNSEXERCISE OF PUT OPTION IN RESPECT OF YGOK SHARES
27th Mar 20199:30 amRNSStabilisation Notice
27th Mar 20198:07 amRNSEvraz Plc Announces Tender Offer Results
27th Mar 20197:09 amRNSEVRAZ announces pricing of U.S.$700m note issue
26th Mar 20199:37 amRNSStabilisation Notice
22nd Mar 20196:28 pmRNSHolding(s) in Company
22nd Mar 20196:27 pmRNSHolding(s) in Company
19th Mar 20196:30 pmRNSHolding(s) in Company
19th Mar 20197:41 amRNSDirector/PDMR Shareholding
19th Mar 20197:33 amRNSCompletion of sale of existing shares of EVRAZ
18th Mar 20194:46 pmRNSIntended sale of existing ordinary shares of EVRAZ
18th Mar 201910:02 amRNSAnnouncement of Tender Offer
13th Mar 20192:40 pmRNSEurobonds Issuer Substitution
13th Mar 20197:35 amRNSDividend - determination of currency amounts
28th Feb 20197:00 amRNSAnnual Financial Report
20th Feb 20198:10 amRNSNOTICE OF 2018 RESULTS AND CONFERENCE CALL DETAILS
31st Jan 20199:00 amRNSEVRAZ Q4 2018 TRADING UPDATE
28th Jan 20196:00 pmRNSHolding(s) in Company
28th Jan 20196:00 pmRNSShareholding notification
27th Dec 20183:42 pmRNSAmendment of transshipment agreement
27th Dec 20187:00 amRNSResponse to Press Speculation
27th Dec 20187:00 amRNSDirector/PDMR Shareholding
24th Dec 20187:04 amRNSHolding(s) in Company
24th Dec 20187:02 amRNSHolding(s) in Company
24th Dec 20187:00 amRNSMajor shareholding notification
28th Nov 20184:20 pmRNSDividend - determination of currency amounts
15th Nov 201812:03 pmRNSThird interim dividend for 2018
25th Oct 20189:45 amRNSEVRAZ Q3 2018 TRADING UPDATE
19th Oct 20187:00 amRNSEVRAZ plc holds Investor Day
17th Oct 201810:03 amRNSDirector/PDMR Shareholding
20th Sep 20183:24 pmRNSUpdate on relationship agreements
10th Sep 20186:00 pmRNSDirector/PDMR Shareholding
4th Sep 201811:22 amRNSHolding(s) in Company
4th Sep 201811:18 amRNSHolding(s) in Company
4th Sep 201811:16 amRNSHolding(s) in Company
4th Sep 201811:15 amRNSMajor shareholding notification
22nd Aug 20183:54 pmRNSDividend - Determination of Currency Amounts
9th Aug 20187:00 amRNSHalf-year Report
8th Aug 20183:34 pmRNSChanges to the Board of Directors
26th Jul 20187:00 amRNSEVRAZ Q2 2018 TRADING UPDATE
19th Jul 20184:20 pmEQSNOTICE OF H1 2018 RESULTS AND CONFERENCE CALL DETAILS
10th Jul 20185:00 pmRNSResult of Court Hearing - Reduction of Capital
26th Jun 20186:30 pmRNSDirector/PDMR Shareholding
25th Jun 201810:20 amRNSEVRAZ Modern Slavery Transparency Statement 2017
19th Jun 201812:47 pmRNSResult of AGM
19th Jun 201810:27 amRNSProvision of guarantee
19th Jun 201810:21 amRNSResults of the General Meeting of shareholders
13th Jun 20185:00 pmRNSReport on payments to governments for 2017
13th Jun 20189:25 amRNSDividend - Determination of Currency Amounts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.